Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
MANAGING THE FIRST-EPISODE OF SCHIZOPHRENIA - THE ROLE OF NEW THERAPIES
Autore:
MCCREADIE RG;
Indirizzi:
CRICHTON ROYAL HOSP DUMFRIES SCOTLAND
Titolo Testata:
European neuropsychopharmacology
, volume: 6, anno: 1996, supplemento:, 2
pagine: 3 - 5
SICI:
0924-977X(1996)6:<3:MTFOS->2.0.ZU;2-7
Fonte:
ISI
Lingua:
ENG
Keywords:
FIRST-EPISODE SCHIZOPHRENIA; EXTRAPYRAMIDAL SYMPTOMS; COMPLIANCE; RISPERIDONE;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Science Citation Index Expanded
Science Citation Index Expanded
Citazioni:
9
Recensione:
Indirizzi per estratti:
Citazione:
R.G. Mccreadie, "MANAGING THE FIRST-EPISODE OF SCHIZOPHRENIA - THE ROLE OF NEW THERAPIES", European neuropsychopharmacology, 6, 1996, pp. 3-5

Abstract

When schizophrenia is first diagnosed antipsychotic therapy should bestarted quickly as the longer the initial psychosis remains untreatedthe worse the final outcome will be. Aggression or agitation is best managed with a sedative given with a non-sedating antipsychotic until the antipsychotic effects of the latter appear. Because patients' first experiences of side effects are important determinants of compliance, serious consideration should be given to using a drug with low extrapyramidal side effect (EPS) liability, e.g. risperidone. In a recent trial in 183 patients with first episode schizophrenia, risperidone wasat least as effective as haloperidol in reducing total PANSS scores, PANSS positive, negative, general psychopathology scores and derived BPRS scores. At endpoint, 63% of the risperidone group had improved by 50% or more (total PANSS) compared with 56% in the haloperidol group. The incidence of EPS was significantly lower in the risperidone group.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/01/20 alle ore 09:47:44